Alnylam Pharmaceuticals, Inc. (ALNY)

318.85 -9.88 (-3.01%) USD  |  NASDAQ  |  Apr 02, 16:00
318.65 -0.20 (-0.06%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Bristol Myers Squibb Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade